Cue Biopharma, Inc. (CUE)
0.4932
+0.02
(+3.33%)
USD |
NASDAQ |
Dec 11, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Research and Development Expense (Quarterly): 4.686M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insmed, Inc. | 186.42M |
| Puma Biotechnology, Inc. | 15.91M |
| Mersana Therapeutics, Inc. | 12.07M |
| Adaptive Biotechnologies Corp. | 20.92M |
| NovaBay Pharmaceuticals, Inc. | -- |